Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raheela Ashfaq

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Journal of the Society for Gynecologic Investigation|June 29, 2004
Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker developmentJayanthi S Lea, Raheela Ashfaq, Sabeeha Muneer, et al.
American Journal of Obstetrics and Gynecology|March 26, 2004
P16 as a molecular biomarker of cervical adenocarcinomaJohn O Schorge, Jayanthi S Lea, Keren J Elias, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 6, 2014
Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control studySamir Gupta, Han Sun, Sang Yi, et al.
European Urology|March 24, 2004
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytologyShahrokh F Shariat, Roberto Casella, Frank H Wians, et al.
Journal of Lower Genital Tract Disease|April 7, 2007
Comparison of human papilloma virus testing and spectroscopy combined with cervical cytology for the detection of high-grade cervical neoplasiaClaudia L Werner, William F Griffith, Raheela Ashfaq, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2002
Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu statusSijian Wang, M Hossein Saboorian, Eugene P Frenkel, et al.
European Urology|July 1, 2008
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patientsAmit Gupta, Yair Lotan, Raheela Ashfaq, et al.
Molecular and Cellular Biology|April 18, 2007
Viable mice with compound mutations in the Wnt/Dvl pathway antagonists nkd1 and nkd2Shu Zhang, Tolga Cagatay, Manami Amanai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 16, 2003
Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expressionDonna E Hansel, Ayman Rahman, John Hermans, et al.
Diagnostic Cytopathology|February 21, 2014
Techniques for cytologic sampling of pancreatic and bile duct lesionsWilliam Brugge, John Dewitt, Jason B Klapman, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Journal of the Society for Gynecologic Investigation|June 29, 2004
Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker developmentJayanthi S Lea, Raheela Ashfaq, Sabeeha Muneer, et al.
American Journal of Obstetrics and Gynecology|March 26, 2004
P16 as a molecular biomarker of cervical adenocarcinomaJohn O Schorge, Jayanthi S Lea, Keren J Elias, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 6, 2014
Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control studySamir Gupta, Han Sun, Sang Yi, et al.
European Urology|March 24, 2004
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytologyShahrokh F Shariat, Roberto Casella, Frank H Wians, et al.
Journal of Lower Genital Tract Disease|April 7, 2007
Comparison of human papilloma virus testing and spectroscopy combined with cervical cytology for the detection of high-grade cervical neoplasiaClaudia L Werner, William F Griffith, Raheela Ashfaq, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2002
Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu statusSijian Wang, M Hossein Saboorian, Eugene P Frenkel, et al.
European Urology|July 1, 2008
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patientsAmit Gupta, Yair Lotan, Raheela Ashfaq, et al.
Molecular and Cellular Biology|April 18, 2007
Viable mice with compound mutations in the Wnt/Dvl pathway antagonists nkd1 and nkd2Shu Zhang, Tolga Cagatay, Manami Amanai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 16, 2003
Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expressionDonna E Hansel, Ayman Rahman, John Hermans, et al.
Diagnostic Cytopathology|February 21, 2014
Techniques for cytologic sampling of pancreatic and bile duct lesionsWilliam Brugge, John Dewitt, Jason B Klapman, et al.
Pageof 12